Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
03/2003
03/20/2003US20030055086 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
03/20/2003US20030055078 Use of phanquinone for the treatment or prevention of memory impairment
03/20/2003US20030055076 Novel compounds, their preparation and use
03/20/2003US20030055071 For therapy, prophylaxis or delaying the onset of AIDS and infection by HIV
03/20/2003US20030055068 Pyrazole compounds useful as protein kinase inhibitors
03/20/2003US20030055061 Therapy of disease or condition which is caused by a disorder of the serotonin system by administering 2,7-substituted octahydro-1H-pyrido(1,2-a)pyrazine derivatives, and their acid addition salts
03/20/2003US20030055059 For therapy of psychiatric disorders and neurological diseases including affective disorder, anxiety, depression, headache, irritable bowel syndrome, post-traumatic stress disorder, supranuclear palsy, immune suppression, Alzheimer's disease
03/20/2003US20030055054 CXCR3 antagonists
03/20/2003US20030055049 For therapy of abnormal cell growth, such as cancer, in mammals
03/20/2003US20030055047 For prevention and/or suppression of preterm labor, suppression of labor at term prior to caesarean delivery, and for the treatment of dysmenorrhea; useful in enhancing fertility rates
03/20/2003US20030055046 Novel pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
03/20/2003US20030055044 Administering pyrazole derivative for inhibiting GSK-3 or Aurora activity in a patient
03/20/2003US20030055043 Substituted azabicyclic moieties for the treatment of disease
03/20/2003US20030055035 Useful in hyperpolarizing cell membranes, opening potassium channels, relaxing smooth muscle cells, and inhibiting bladder contractions
03/20/2003US20030055021 Compounds for the treatment of ischemia
03/20/2003US20030054200 Organic electroluminescence device
03/20/2003US20030053949 Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
03/20/2003CA2460345A1 2-aroylimidazole compounds for treating cancer
03/20/2003CA2459973A1 Carbazole derivatives and their use as npy5 receptor antagonists
03/20/2003CA2459886A1 1-glyoxlylamide indolizines for treating cancer
03/20/2003CA2457717A1 Use of compounds in a dry powder inhaler
03/19/2003EP1292596A1 1,3,8-triaza-spiro[4,5]decan-4-one derivatives as neurokinin receptor antagonists
03/19/2003EP1292576A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
03/19/2003EP1292304A1 Zolpidem hemitartrate
03/19/2003EP1292269A1 Agent for dyeing keratin containing fibers
03/19/2003EP1114049B1 3-bicycloindole compounds as 5-ht1d receptor ligands
03/19/2003EP1104765B1 Process for preparing n,n,6- trimethyl-2 -(4-methylphenyl)- imidazo-[1,2-a] -pyridine-3- acetamide and salts thereof
03/19/2003EP1012131B1 Enantioselective reduction of ketones with a silane agent/metal compound/chiral ligand system
03/19/2003CN1404483A New AZa-indolyl derivatives
03/19/2003CN1404478A Pyridinylimidazoles
03/19/2003CN1404472A Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
03/19/2003CN1404392A Antiviral azaindole derivatives
03/19/2003CN1403453A Quinoline and quinazoline compound for treating benign prostatic hyperplasia specially
03/18/2003US6534654 Process for preparing imidazoquinolinamines
03/18/2003US6534545 Unsaturated derivatives at the 4-position of 6-tert-butyl-1,1-dimethylindane and their use in human and veterinary medicine and cosmetics
03/18/2003US6534535 Inhibitors of factor Xa
03/18/2003US6534522 Subtype-selective NMDA receptor ligands and the use thereof
03/18/2003US6534521 Useful in the treatment of inflammation, atherosclerosis, restenosis, and immune disorders such as arthritis and transplant rejection
03/18/2003US6534520 Antiviral compounds
03/18/2003US6534517 A polycyclic or heteropolycyclic compound containing amide or carboxy groups useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the peroxisome proliferator-activated receptor(PPAR)
03/18/2003US6534516 Method of affecting androgen receptor activity comprising the in vivo administration of a composition
03/18/2003US6534515 20,21-dinor-eburnamenines
03/18/2003US6534511 The use of certain 6-arylpyrazolo(3,4-d)pyrimidin-4-ones, 2 arylquinazolin-4-ones, 2-arylpurin-6-ones and 2-arylpyrido(3,2- d)pyrimidin-4-ones, or a pharmaceutically acceptable salt thereof, forsexual disorders
03/18/2003US6534510 Anticoagulants
03/18/2003US6534492 Uracil substituted phenyl sulfamoyl carboxamides
03/18/2003US6534491 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
03/18/2003US6534092 Method for preparing microparticles having a selected polymer molecular weight
03/18/2003US6534040 Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
03/18/2003CA2362944C Optical isomers of ¬3-(1,1-dialkylated)-1-aminomethyl-pyrrolidine|
03/18/2003CA2272705C Fused bicyclic pyrimidine derivatives
03/18/2003CA2244501C Arylsulfonylamino hydroxamic acid derivatives
03/18/2003CA2236239C Quinoline and quinazoline compounds useful in therapy
03/14/2003WO2002023991A1 Use of riboflavin and flavin derivatives as chitinase inhibitors
03/14/2003CA2422584A1 Use of riboflavin and flavin derivatives as chitinase inhibitors
03/13/2003WO2003020700A2 SUBSTITUTED INDENO[1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF
03/13/2003WO2003020280A2 Compositions and use thereof in the treatment of cancer
03/13/2003WO2002088080A3 Dual inhibitors of pde 7 and pde 4
03/13/2003WO2002087513A3 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
03/13/2003WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications
03/13/2003WO2002066469A3 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
03/13/2003WO2002066427A3 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof
03/13/2003WO2002046191A3 Urea substituted imidazoquinoline ethers
03/13/2003WO2002046188A3 Amido ether substituted imidazoquinolines
03/13/2003WO2002036554A3 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
03/13/2003WO2002022563A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient
03/13/2003US20030050476 Novel indolizine compound, production process for novel indolizine compound, organic light-emitting device material having indolizine skeleton, and organic light-emitting device using these
03/13/2003US20030050321 Salt of naphthyridine carboxylic acid derivative
03/13/2003US20030050320 A therapeutic agent for treating hepatitis C, based on polymerase inhibitory activity
03/13/2003US20030049643 G protein-coupled receptors for use in the treatment of cardiovascular, nervous system, angina pectoris, inflamatory bowel, allergies and gastrointestinal disorders
03/13/2003CA2459584A1 Compositions and use thereof in the treatment of cancer
03/13/2003CA2458399A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments
03/13/2003CA2457534A1 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
03/13/2003CA2422135A1 Urea derivatives and adhesion molecule inhibitors containing the same as effective ingredients
03/12/2003EP1290448A2 Rare earth metal cryptates showing reduced fluorescence quenching
03/12/2003EP1289999A1 Antitumoral analogs of et-743
03/12/2003EP1289996A1 Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands
03/12/2003EP1289993A1 Caspase inhibitors and uses thereof
03/12/2003EP1289990A1 Tetracyclic diketopierazine compounds as pdev inhibitors
03/12/2003EP1289989A2 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
03/12/2003EP1289988A1 1,4-diazabicyclo 3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof
03/12/2003EP1289987A1 4-(2-phenylthiazol-5-yl)-1,4-diazabicyclo- 3.2.2]nonane derivatives, preparation and therapeutic use thereof
03/12/2003EP1289986A1 1,4-diazabicyclo 3.2.2]nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
03/12/2003EP1289985A2 Beta-carboline derivatives useful as inhibitors of phosphodiesterase
03/12/2003EP1289983A2 Heteroarylalkanoic acids as integrin receptor antagonists
03/12/2003EP1289960A2 Cycloalkyl alkanoic acids as integrin receptor antagonists
03/12/2003EP1289955A1 Piperidines for use as orexin receptor antagonists
03/12/2003EP1289526A1 Melanocortin receptor agonists
03/12/2003EP1075477B1 Novel Benzonaphthyridine-N-oxides
03/12/2003EP1012144B1 Method for producing (hetero)aromatic hydroxylamines
03/12/2003EP0937074B1 Benzonaphthyridines as bronchial therapeutics
03/12/2003EP0934064B1 Thrombin inhibitors
03/12/2003EP0672031B1 Catechol diethers as selective pde iv inhibitors
03/12/2003CN1402727A Bicyclic imidazo-3-yl-amine derivs. which are substd. on sixth ring
03/12/2003CN1402726A Bicyclic imidazo-5-yl-amine derivs.
03/12/2003CN1402725A Diketopiperazine derivs. to inhibit thrombin
03/12/2003CN1402721A Benzoimidazole derivs. useful as antiproliferative agents
03/12/2003CN1402710A Antipicornaviral compound and compositions, their pharmaceutical uses, and material for their synthesis
03/12/2003CN1401648A Heterocycle substd. condensed heterocyclic derivs. with bioactivity
03/11/2003US6531632 Bis-o-aminophenols and o-aminophenolcarboxylic acids and process for preparing the same
03/11/2003US6531594 Process for producing 1H-3-aminopyrrolidine and derivatives thereof